AVTX
Avalo Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:58 PM EST
7.75USD+0.649%(+0.05)974,091
Pre-marketNov 13, 2026 8:34:30 AM EST
7.75USD+0.649%(+0.05)
After-hoursNov 13, 2026 4:00:30 PM EST
7.76USD+0.129%(+0.01)
AVTX Financials
In Q3 FY 2026 (ended ), Avalo Therapeutics, Inc. Common Stock (AVTX) reported net income of −$18.95M, operating cash flow of −$11.54M, and assets of $481.43M (filed ).
Loading financial flows…